Unitedhealth Group Inc financial statements, FY2006–FY2025
Unitedhealth Group Inc reported revenue of $448B and net income of $12.1B for the fiscal year ended 2025-12-31, as stated in its filing with US SEC EDGAR. Listed as UNH (NYSE). Fiscal year ends 31 December.
FactReportedAnnual figures as reported, in USD, 6 measures over 20 fiscal years. Each value links to the filing it came from. Nothing is restated, annualised, converted or estimated; a period a filing did not state is shown as a gap.
Annual results by fiscal year
| Fiscal year end | Revenue | Operating income | Net income | Total assets | Total liabilities | Stockholders' equity |
|---|---|---|---|---|---|---|
| 2025-12-31 | $448B | $19B | $12.1B | $310B | $208B | — |
| 2024-12-31 | $400B | $32.3B | $14.4B | $298B | $196B | — |
| 2023-12-31 | $372B | $32.4B | $22.4B | $274B | $175B | — |
| 2022-12-31 | $324B | $28.4B | $20.1B | $246B | $159B | — |
| 2021-12-31 | $288B | $24B | $17.3B | $212B | $136B | — |
| 2020-12-31 | $257B | $22.4B | $15.4B | $197B | $127B | — |
| 2019-12-31 | $242B | $19.7B | $13.8B | $174B | $112B | — |
| 2018-12-31 | $226B | $17.3B | $12B | $152B | $96B | — |
| 2017-12-31 | $201B | $15.2B | $10.6B | $139B | $87B | — |
| 2016-12-31 | $185B | $12.9B | $7.02B | $123B | $82.6B | — |
| 2015-12-31 | $157B | $11B | $5.81B | $111B | $75.8B | — |
| 2014-12-31 | $130B | $10.3B | $5.62B | $86.3B | $52.5B | $32.5B |
| 2013-12-31 | $122B | $9.62B | $5.63B | $81.9B | $48.6B | $32.1B |
| 2012-12-31 | $111B | $9.25B | $5.53B | $80.9B | $47.6B | $31.2B |
| 2011-12-31 | $102B | $8.46B | $5.14B | $67.9B | $39.6B | $28.3B |
| 2010-12-31 | $94.2B | $7.86B | $4.63B | $63.1B | $37.2B | $25.8B |
| 2009-12-31 | $87.1B | $6.36B | $3.82B | $59B | $35.4B | $23.6B |
| 2008-12-31 | $81.2B | $5.26B | $2.98B | $55.8B | $35B | $20.8B |
| 2007-12-31 | $75.4B | $7.85B | $4.65B | — | — | $20.1B |
| 2006-12-31 | — | — | — | — | — | $20.8B |
About these figures
Every number on this page is a fact with a filing behind it, retrieved from US SEC EDGAR and stored with the period it belongs to. Figures are shown as the company reported them for that period; a later restatement supersedes the earlier value rather than overwriting it. Market capitalisation is not shown anywhere on this site because no licensed price source is used; the profile shows reported public float where a filing states it.